WARNING:
JavaScript is turned OFF. None of the links on this concept map will
work until it is reactivated.
If you need help turning JavaScript On, click here.
This Concept Map, created with IHMC CmapTools, has information related to: Mets Brain Tumors efficacy endpoints v1, Time To Salvage Therapy measured by Date of Salvage Therapy, Tumor Subtype include Lung, MRI has types - With contrast - Without contrast - FLAIR, Surgical Intervention has type Chemotherapy wafers, Enhancing classified as Non-measurable lesions, Sum of the product of all lesions has outcomes -Complete Response (CR) -Partial Response (PR) -Stable disease (SD) -Progression, perpendicular diameter measured in plane, Progression free survival (PFS) has subtypes Extracranial, Molecular Characteristics determined by Method of detection, Qualitative Assessment has attribute - better - same - worse, New lesion identified by Organ specific lesion ID, Regional includes Convection enhanced delivery, Immunohistochemistry has Target, Perfusion measured in rCBV, PRIMARY BRAIN TUMORS (HGG) EFFICACY ENDPOINTS include Overall Survival (OS), Enhancing classified as Existing lesion, Sum of the product of all lesions includes Total area of each leasion, Objective Response Rate (ORR) derived from Tumor Response, Repeated concepts/instances throughout the CMAP are denoted by dotted outline, Regional includes Surgical Intervention